Stockysis — AI-Powered Stock News & Sentiment Analysis

D. Boral Capital Downgrades Reviva Pharmaceuticals to Hold

Benzinga Newsdesk www.benzinga.com Negative 90.3%

Neg 90.3% Neu 0% Pos 0%

D. Boral Capital analyst Jason Kolbert downgrades Reviva Pharmaceuticals (NASDAQ:RVPH) from Buy to Hold.

Comments

No comments yet. Be the first!